Schwedt, Todd J.
Myers Oakes, Tina M. http://orcid.org/0009-0008-4507-6056
Martinez, James M.
Vargas, Bert B.
Pandey, Hitendra
Pearlman, Eric M.
Richardson, Diane R.
Varnado, Oralee J.
Cobas Meyer, Michael
Goadsby, Peter J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
https://doi.org/10.1007/s40120-023-00562-w
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 6 September 2023
Accepted: 24 October 2023
First Online: 10 November 2023
Declarations
:
: Todd Schwedt has received compensation for <i>consulting</i> for Abbvie, Allergan, Axsome, Collegium, Eli Lilly, Linpharma, Lundbeck, Satsuma, and Theranica; <i>research funding</i> from Amgen, Mayo Clinic, National Institutes of Health, Patient Centered Outcomes Research Institute, SPARK Neuro, and the United States Department of Defense; <i>stock options</i> in Aural Analytics and Nocira; and is on the <i>board of directors</i> for the American Headache Society and the American Migraine Foundation. Peter Goadsby reports, over the last 36 months, a <i>grant</i> from Celgene; <i>personal fees</i> from Aeon Biopharma, Abbvie, Amgen, CoolTech LLC, Dr Reddys, Eli Lilly and Company, Epalex, Lundbeck, Novartis, Pfizer, Praxis, Sanofi, Satsuma, Shiratronics, Teva Pharmaceuticals, and Tremeau; <i>personal fees for advice</i> through Gerson Lehrman Group, Guidepoint, SAI Med Partners, and Vector Metric; <i>fees for educational materials</i> from CME Outfitters; <i>publishing royalties or fees</i> from Massachusetts Medical Society, Oxford University Press, UptoDate, and Wolters Kluwer; and a <i>patent</i> for magnetic stimulation for headache (no. WO2016090333 A1) assigned to eNeura without fee. James Martinez, Michael Cobas Meyer, Tina Myers Oakes, Hitendra Pandey, Eric Pearlman, Diane Richardson, Bert Vargas, and Oralee Varnado are employees of Eli Lilly and Company, Indianapolis, IN, USA.
: The study was approved by all institutions and the Advara, Inc. Institutional Review Board (Columbia, MD) utilized by all investigative sites that participated in the study (Table S2 in the electronic supplementary material). The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All participants provided informed consent to participate in the study.